Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year
26 juil. 2018 07h00 HE
|
ABIOMED, Inc.
DANVERS, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- ABIOMED, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported first quarter fiscal 2019...
Abiomed First Quarter Fiscal 2019 Earnings And Conference Call Notification
06 juil. 2018 08h00 HE
|
ABIOMED, Inc.
DANVERS, Mass., July 06, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 26, 2018, the Company will release financial results for the first quarter of fiscal...
Abiomed to Present at the Jefferies 2018 Healthcare Conference
29 mai 2018 08h00 HE
|
ABIOMED, Inc.
DANVERS, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
アビオメッドの2018年度第4四半期の収入は40%増の1億7,400万ドル、通年の収入は前年度比で33%増の5億9,400万ドル
03 mai 2018 19h55 HE
|
ABIOMED, Inc.
米国マサチューセッツ州ダンバース, May 04, 2018 (GLOBE NEWSWIRE) -- 画期的な心臓復元およびサポートテクノロジーのリーディングプロバイダーであるアビオメッド (ABIOMED, Inc.、NASDAQ:ABMD) は本日、2018年度第4四半期に1億7,440万ドル (約190億7,000万円) の収入を計上し、2017年度同期の1億2,470万ドル...
Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year
03 mai 2018 07h00 HE
|
ABIOMED, Inc.
DANVERS, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- ABIOMED, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported fourth quarter fiscal 2018...
Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification
13 avr. 2018 08h00 HE
|
ABIOMED, Inc.
DANVERS, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, May 3, 2018, the Company will release financial results for the fourth quarter of fiscal...
Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg
04 avr. 2018 08h00 HE
|
ABIOMED, Inc.
DANVERS, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, announced today that the Impella...
Abiomed Receives FDA Approval for Impella CP® with SmartAssist™ and Optical Sensor
02 avr. 2018 08h00 HE
|
ABIOMED, Inc.
DANVERS, Mass., April 02, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received U.S....
アビオメッド、トッド･a･トラップを新しい最高財務責任者に任命
02 avr. 2018 05h59 HE
|
ABIOMED, Inc.
マサチューセッツ州ダンバース, April 02, 2018 (GLOBE NEWSWIRE) -- 画期的な心臓サポートテクノロジーのリーディングプロバイダーであるアビオメッド (Abiomed, Inc.、NASDAQ: ABMD) は本日、2018年4月9日付でトッド･A･トラップ (Todd A. Trapp) をバイスプレジデント兼最高財務責任者に任命することを発表した。 同氏...
Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
30 mars 2018 09h06 HE
|
ABIOMED, Inc.
DANVERS, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Todd A. Trapp will be appointed as...